Patient Guide: VMT01-T101: A Phase I/IIa, First-in-Human, Multicenter Dose Escalation and Dose Expansion Study of [203/212Pb] VMT01 Receptor-targeted, Image-guided Alpha-particle Therapy in Patients with Previously Treated Unresectable or Metastatic Melanoma

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at multiple participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCT20240736
Status: 🟢 Enrolling Now
Condition: Melanoma
Phase: PHASE1, PHASE2

Loading interactive enrollment tools...

The full interactive experience will load momentarily